Betaxolol hydrochloride CAS: 63659-19-8

CAS NO: 63659-19-8
Betaxolol hydrochloride
CBNumber: CB3153329
Chemical Name: Betaxolol hydrochloride
Molecular Formula: C18H30ClNO3
Formula Weight: 343.89
CAS No.: 63659-19-8
Description Review
Description

Betaxolol hydrochloride, also known as Betoptic, is a medication used to treat high blood pressure and glaucoma. It is a beta-blocker, which works by blocking the effects of adrenaline and other stress hormones, thereby reducing the heart rate and relaxing blood vessels. This drug was first approved in 1985 and has since been widely used for treating various medical conditions.

Chemical Name:

The chemical name of Betaxolol hydrochloride is (RS)-1-[4-(2-methylpropoxy)phenyl]ethanol hydrochloride.

Molecular Formula:

The molecular formula of Betaxolol hydrochloride is C18H29NO3.HCl.

Formula Weight:

The formula weight of Betaxolol hydrochloride is 343.9 g/mol.

CAS No:

The CAS number of Betaxolol hydrochloride is 63659-19-8.

Top Ten Keywords from Google and Synonyms:

  1. Glaucoma medication
  2. Beta-blocker drug
  3. High blood pressure treatment
  4. Ocular hypertension therapy
  5. Betoptic
  6. Cardiovascular medication
  7. Antihypertensive drug
  8. Adrenergic receptor antagonist
  9. Eye drops for glaucoma
  10. IOP-lowering medication

Synonyms: Betaxolol HCl, Betaxolol Hydrochloride, Betaxololum, Betoptic-S, Kerlone

Health Benefits of Betaxolol Hydrochloride:

Betaxolol hydrochloride is primarily used to treat high blood pressure and glaucoma. It helps in lowering the intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which can help prevent vision loss. In addition, Betaxolol hydrochloride can also reduce the risk of heart attacks, strokes, and other cardiovascular diseases in people with hypertension.

Potential Effects:

Betaxolol hydrochloride is a beta-blocker that blocks the effects of adrenaline on the heart and blood vessels. It reduces heart rate, relaxes blood vessels, and decreases the force of the heart's contractions. As a result, it lowers blood pressure and reduces intraocular pressure in the eyes.

Product Mechanism:

Betaxolol hydrochloride works by blocking the beta-adrenergic receptors in the heart and blood vessels. These receptors are responsible for the body's response to adrenaline and other stress hormones. When blocked, the heart rate slows down, blood vessels dilate, and blood pressure decreases. This mechanism also reduces the production of aqueous humor in the eye, which helps reduce intraocular pressure.

Safety:

Betaxolol hydrochloride is generally considered safe when used as directed. However, like all medications, it may cause side effects in some people. It is not recommended for certain patients, such as those who have asthma, severe bradycardia, or heart block. It should also be used with caution in people with diabetes, kidney disease, liver disease, or thyroid disorders.

Side Effects:

Common side effects of Betaxolol hydrochloride include fatigue, dizziness, headache, diarrhea, nausea, and dry eyes. Rare but serious side effects may include chest pain, shortness of breath, slow or irregular heartbeat, fainting, and allergic reactions. Patients who experience any of these symptoms should seek immediate medical attention.

Dosing Information:

The recommended dose of Betaxolol hydrochloride for hypertension is 10 mg once daily, which may be increased to 20 mg once daily if needed. For glaucoma, the usual dose is one drop of 0.25% or 0.5% Betaxolol hydrochloride solution in the affected eye(s), twice daily.

Conclusion:

Betaxolol hydrochloride is a beta-blocker drug used to treat high blood pressure and glaucoma. It works by blocking the beta-adrenergic receptors in the heart and blood vessels, reducing heart rate, relaxing blood vessels, and decreasing intraocular pressure in the eyes. While it is generally safe and effective, it may cause side effects in some patients and is not recommended for certain populations. If you have any questions about Betaxolol hydrochloride or its use, please consult your healthcare provider

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code